Ad is loading...
JVMRX
Price
$31.39
Change
-$0.23 (-0.73%)
Updated
Nov 15 closing price
LMCPX
Price
$36.53
Change
-$0.31 (-0.84%)
Updated
Nov 15 closing price
Ad is loading...

JVMRX vs LMCPX

Header iconJVMRX vs LMCPX Comparison
Open Charts JVMRX vs LMCPXBanner chart's image
JHancock Disciplined Value Mid Cap R6
Price$31.39
Change-$0.23 (-0.73%)
VolumeN/A
CapitalizationN/A
Lord Abbett Mid Cap Stock P
Price$36.53
Change-$0.31 (-0.84%)
VolumeN/A
CapitalizationN/A
JVMRX vs LMCPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMRX vs. LMCPX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMRX is a Buy and LMCPX is a Buy.

FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 23.8B vs. LMCPX (1.23B). JVMRX pays higher dividends than LMCPX: JVMRX (0.93) vs LMCPX (0.32). JVMRX was incepted earlier than LMCPX: JVMRX (13 years) vs LMCPX (27 years). JVMRX (41.00) and LMCPX (41.00) have comparable annual turnover. LMCPX has a lower initial minimum investment than JVMRX: LMCPX (0) vs JVMRX (1000000). LMCPX annual gain was more profitable for investors over the last year : 28.55 vs. JVMRX (21.74). JVMRX return over 5 years is better than : 45.54 vs. LMCPX (34.66).
JVMRXLMCPXJVMRX / LMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years27 years-
Gain YTD14.73018.41280%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.8B1.23B1,938%
Annual Yield % from dividends0.930.32288%
Returns for 1 year21.7428.5576%
Returns for 3 years7.783.32234%
Returns for 5 years45.5434.66131%
Returns for 10 years63.3953.33119%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOUS3.970.02
+0.51%
Anywhere Real Estate
JKHY173.210.76
+0.44%
Jack Henry & Associates
YELP35.95-0.48
-1.32%
YELP
GTBP2.92-0.09
-2.99%
GT Biopharma
TELA2.92-0.12
-3.95%
TELA Bio